EFS – ETABLISSEMENT FRANCAIS DU SANG
The WP3 Leader is responsible for the evaluation of the project results in terms of high quality deliverables produced and milestones reached, as well as meeting reports and all other relevant data and information. The constant monitoring and assessment of all the activities carried out will both stimulate a greater effort to be made by all partners and increase confidence in the project’s results. An Advisory Board will be established and it will assess the performance of the Consortium partners through the identification of specific indicators.
M.D., Ph.D., and clinical haematologist at the Besançon University Hospital until 2009, Pierre Tiberghien has headed the Bourgogne France-Comté Etablissement Français du Sang (EFS)(2005-2009) as well a University INSERM EFS research laboratory on host-graft immune interactions (2002-2008). Professor of medicine (immunology, transfusion) at the Franche-Comté University. He was EFS deputy CEO for medicine and research from 2009 to 2017 and is currently senior advisor for European and international medical and scientific affairs. Pierre Tiberghien is currently vice-president of the European Blood Alliance.
Transpose project news
- February 21, 2020
- November 27, 2019
- August 8, 2019
- May 13, 2019